Market dialogue, Trombaferesis machine
Value
Estimated—
Awarded—
Who already wins at this buyer
Firms with recorded awards from Oslo Universitetssykehus HF (hovedenhet) in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| Matriks AS | 2 | €1,802,468 | 2026-09-15 |
| Biotage Sweden AB | 2 | €311,227 | 2026-07-22 |
| AGILENT DGG NORGE AS | Roche Diagnostics Norge AS | 1 | €24,957,249 | 2026-09-09 |
| DiaSorin AB | 1 | €2,421,672 | 2026-06-16 |
| TRIOLAB AS | 1 | €1,086,317 | 2026-06-17 |
Full buyer profile: what Oslo Universitetssykehus HF (hovedenhet) buys and who wins it →
CPV codes
33000000 Medical equipment & pharmaceuticals33194210 Medical equipment & pharmaceuticals33194220 Medical equipment & pharmaceuticals38000000 Laboratory, optical & precision equipmentDescription
Oslo University Hospital HF (OUS) invites suppliers of thrombapheresis to provide input in a RFI. OUS plans to establish parallel framework agreements with up to two suppliers, for a contract period of four years, with an estimated total volume of 8 machines and a maximum total volume of 10 machines. The equipment is to be used for thrombapheresis from blood donors with simultaneous plasma collection. Enclosed are the market dialogue document with further information, and a response form containing the questions we would like answered. The completed form should be submitted via the communication module in Mercell by 09 October 2026, 12:00 noon. Questions relating to the market dialogue should be submitted through the same channel. The market dialogue does not constitute a tender competition and entails no obligation for OUS to carry out a procurement. It is conducted as a preliminary market investigation pursuant to Section 12-1 of the Norwegian Public Procurement Regulations (forskrift om offentlige anskaffelser, FOA). Input received will be considered, but OUS remains free to design the procurement independently of it. Participation is not remunerated and confers neither an advantage nor a disadvantage in any subsequent competition.
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-06-24 | Outer machine for the Department of Microbiology and Infection Protection with UNN HF Tromsø. | SYKEHUSINNKJØP HF NO | 91% |
| 2026-05-19 | 77450 UL KLM PAT, automated histology instrument | Oslo Universitetssykehus HF (hovedenhet) NO | 91% |
| 2026-07-09 | Analysis, research and consultancy services within ICT for health companies in Helse Sør-Øst | SYKEHUSINNKJØP HF NO | 90% |
| 2026-09-18 | 77030 Laboratory automation: consultation of competition documents. | Oslo Universitetssykehus HF (hovedenhet) NO | 90% |
| 2026-07-13 | Market dialogue: Framework agreement for groceries | Troms Fylkeskommune NO | 90% |
| 2026-05-04 | 78102 RA KRE KRF Automatic electrophores instruments for RNA and DNA (2 items) | Oslo Universitetssykehus HF (hovedenhet) NO | 90% |